Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 7/10

vs
industry
vs
history
Cash to Debt 0.59
OCPNY's Cash to Debt is ranked lower than
63% of the 192 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.21 vs. OCPNY: 0.59 )
Ranked among companies with meaningful Cash to Debt only.
OCPNY' s 10-Year Cash to Debt Range
Min: 0.21  Med: 0.44 Max: N/A
Current: 0.59
Equity to Asset 0.33
OCPNY's Equity to Asset is ranked lower than
84% of the 181 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.60 vs. OCPNY: 0.33 )
Ranked among companies with meaningful Equity to Asset only.
OCPNY' s 10-Year Equity to Asset Range
Min: 0.05  Med: 0.30 Max: 0.37
Current: 0.33
0.05
0.37
Interest Coverage 10.20
OCPNY's Interest Coverage is ranked lower than
72% of the 111 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 53.79 vs. OCPNY: 10.20 )
Ranked among companies with meaningful Interest Coverage only.
OCPNY' s 10-Year Interest Coverage Range
Min: 2.14  Med: 5.63 Max: 9999.99
Current: 10.2
2.14
9999.99
F-Score: 6
Z-Score: 2.39
WACC vs ROIC
7.74%
16.56%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 5/10

vs
industry
vs
history
Operating margin (%) 11.90
OCPNY's Operating margin (%) is ranked higher than
63% of the 189 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 5.48 vs. OCPNY: 11.90 )
Ranked among companies with meaningful Operating margin (%) only.
OCPNY' s 10-Year Operating margin (%) Range
Min: 2.85  Med: 7.61 Max: 11.9
Current: 11.9
2.85
11.9
Net-margin (%) -1.16
OCPNY's Net-margin (%) is ranked lower than
62% of the 189 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.54 vs. OCPNY: -1.16 )
Ranked among companies with meaningful Net-margin (%) only.
OCPNY' s 10-Year Net-margin (%) Range
Min: -11.71  Med: 1.93 Max: 5.41
Current: -1.16
-11.71
5.41
ROE (%) -2.42
OCPNY's ROE (%) is ranked lower than
63% of the 182 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.29 vs. OCPNY: -2.42 )
Ranked among companies with meaningful ROE (%) only.
OCPNY' s 10-Year ROE (%) Range
Min: -62.3  Med: 6.16 Max: 25.76
Current: -2.42
-62.3
25.76
ROA (%) -0.85
OCPNY's ROA (%) is ranked lower than
61% of the 193 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.43 vs. OCPNY: -0.85 )
Ranked among companies with meaningful ROA (%) only.
OCPNY' s 10-Year ROA (%) Range
Min: -9.32  Med: 1.79 Max: 5.21
Current: -0.85
-9.32
5.21
ROC (Joel Greenblatt) (%) 6.71
OCPNY's ROC (Joel Greenblatt) (%) is ranked lower than
54% of the 191 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 11.56 vs. OCPNY: 6.71 )
Ranked among companies with meaningful ROC (Joel Greenblatt) (%) only.
OCPNY' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: -28.73  Med: 25.30 Max: 45.88
Current: 6.71
-28.73
45.88
Revenue Growth (3Y)(%) -11.10
OCPNY's Revenue Growth (3Y)(%) is ranked lower than
83% of the 151 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 5.00 vs. OCPNY: -11.10 )
Ranked among companies with meaningful Revenue Growth (3Y)(%) only.
OCPNY' s 10-Year Revenue Growth (3Y)(%) Range
Min: -12  Med: 0.30 Max: 19.4
Current: -11.1
-12
19.4
EBITDA Growth (3Y)(%) 1.80
OCPNY's EBITDA Growth (3Y)(%) is ranked lower than
64% of the 128 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 7.70 vs. OCPNY: 1.80 )
Ranked among companies with meaningful EBITDA Growth (3Y)(%) only.
OCPNY' s 10-Year EBITDA Growth (3Y)(%) Range
Min: 0  Med: -6.90 Max: 41.5
Current: 1.8
0
41.5
EPS Growth (3Y)(%) -48.20
OCPNY's EPS Growth (3Y)(%) is ranked lower than
95% of the 126 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.70 vs. OCPNY: -48.20 )
Ranked among companies with meaningful EPS Growth (3Y)(%) only.
OCPNY' s 10-Year EPS Growth (3Y)(%) Range
Min: -59.4  Med: 2.50 Max: 135.6
Current: -48.2
-59.4
135.6
» OCPNY's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Insider Trades

Latest Guru Trades with OCPNY

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
Forward P/E 200.00
OCPNY's Forward P/E is ranked lower than
97% of the 75 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 21.74 vs. OCPNY: 200.00 )
Ranked among companies with meaningful Forward P/E only.
N/A
P/B 4.25
OCPNY's P/B is ranked lower than
66% of the 178 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.91 vs. OCPNY: 4.25 )
Ranked among companies with meaningful P/B only.
OCPNY' s 10-Year P/B Range
Min: 1.52  Med: 3.98 Max: 20.67
Current: 4.25
1.52
20.67
P/S 1.98
OCPNY's P/S is ranked higher than
59% of the 190 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.67 vs. OCPNY: 1.98 )
Ranked among companies with meaningful P/S only.
OCPNY' s 10-Year P/S Range
Min: 0.15  Med: 0.82 Max: 3.12
Current: 1.98
0.15
3.12
PFCF 107.40
OCPNY's PFCF is ranked lower than
90% of the 83 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 28.56 vs. OCPNY: 107.40 )
Ranked among companies with meaningful PFCF only.
OCPNY' s 10-Year PFCF Range
Min: 19.12  Med: 77.00 Max: 1025.32
Current: 107.4
19.12
1025.32
POCF 51.16
OCPNY's POCF is ranked lower than
86% of the 114 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 19.43 vs. OCPNY: 51.16 )
Ranked among companies with meaningful POCF only.
OCPNY' s 10-Year POCF Range
Min: 3.03  Med: 27.96 Max: 133.72
Current: 51.16
3.03
133.72
EV-to-EBIT 92.92
OCPNY's EV-to-EBIT is ranked lower than
93% of the 120 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 19.58 vs. OCPNY: 92.92 )
Ranked among companies with meaningful EV-to-EBIT only.
OCPNY' s 10-Year EV-to-EBIT Range
Min: 16.1  Med: 23.50 Max: 82.7
Current: 92.92
16.1
82.7
Shiller P/E 354.09
OCPNY's Shiller P/E is ranked lower than
99% of the 80 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 30.14 vs. OCPNY: 354.09 )
Ranked among companies with meaningful Shiller P/E only.
OCPNY' s 10-Year Shiller P/E Range
Min: 329.78  Med: 348.15 Max: 386.26
Current: 354.09
329.78
386.26
Current Ratio 1.54
OCPNY's Current Ratio is ranked lower than
74% of the 185 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.41 vs. OCPNY: 1.54 )
Ranked among companies with meaningful Current Ratio only.
OCPNY' s 10-Year Current Ratio Range
Min: 0.82  Med: 1.48 Max: 2.09
Current: 1.54
0.82
2.09
Quick Ratio 1.25
OCPNY's Quick Ratio is ranked lower than
62% of the 185 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.60 vs. OCPNY: 1.25 )
Ranked among companies with meaningful Quick Ratio only.
OCPNY' s 10-Year Quick Ratio Range
Min: 0.65  Med: 1.13 Max: 1.73
Current: 1.25
0.65
1.73
Days Inventory 145.22
OCPNY's Days Inventory is ranked lower than
58% of the 183 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 128.59 vs. OCPNY: 145.22 )
Ranked among companies with meaningful Days Inventory only.
OCPNY' s 10-Year Days Inventory Range
Min: 54.63  Med: 74.12 Max: 136.79
Current: 145.22
54.63
136.79

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield 0.22
OCPNY's Dividend Yield is ranked lower than
91% of the 149 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.45 vs. OCPNY: 0.22 )
Ranked among companies with meaningful Dividend Yield only.
OCPNY' s 10-Year Dividend Yield Range
Min: 0.2  Med: 1.13 Max: 3.26
Current: 0.22
0.2
3.26
Yield on cost (5-Year) 0.22
OCPNY's Yield on cost (5-Year) is ranked lower than
88% of the 152 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.61 vs. OCPNY: 0.22 )
Ranked among companies with meaningful Yield on cost (5-Year) only.
OCPNY' s 10-Year Yield on cost (5-Year) Range
Min: 0.2  Med: 1.13 Max: 3.26
Current: 0.22
0.2
3.26
Share Buyback Rate -8.60
OCPNY's Share Buyback Rate is ranked lower than
71% of the 132 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: -2.30 vs. OCPNY: -8.60 )
Ranked among companies with meaningful Share Buyback Rate only.
OCPNY' s 10-Year Share Buyback Rate Range
Min: 0.2  Med: -0.10 Max: -8.6
Current: -8.6

Valuation & Return

vs
industry
vs
history
Price/Tangible Book 8.58
OCPNY's Price/Tangible Book is ranked lower than
76% of the 157 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.27 vs. OCPNY: 8.58 )
Ranked among companies with meaningful Price/Tangible Book only.
OCPNY' s 10-Year Price/Tangible Book Range
Min: 2.17  Med: 2.62 Max: 8.73
Current: 8.58
2.17
8.73
Price/Projected FCF 4.22
OCPNY's Price/Projected FCF is ranked lower than
84% of the 95 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.76 vs. OCPNY: 4.22 )
Ranked among companies with meaningful Price/Projected FCF only.
OCPNY' s 10-Year Price/Projected FCF Range
Min: 3.86  Med: 4.09 Max: 4.4
Current: 4.22
3.86
4.4
Price/Median PS Value 2.02
OCPNY's Price/Median PS Value is ranked lower than
91% of the 166 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.15 vs. OCPNY: 2.02 )
Ranked among companies with meaningful Price/Median PS Value only.
OCPNY' s 10-Year Price/Median PS Value Range
Min: 0.52  Med: 1.00 Max: 2.44
Current: 2.02
0.52
2.44
Earnings Yield (Greenblatt) (%) 1.10
OCPNY's Earnings Yield (Greenblatt) (%) is ranked lower than
61% of the 184 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.90 vs. OCPNY: 1.10 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) (%) only.
OCPNY' s 10-Year Earnings Yield (Greenblatt) (%) Range
Min: 1.1  Med: 4.30 Max: 6.2
Current: 1.1
1.1
6.2
Forward Rate of Return (Yacktman) (%) -11.24
OCPNY's Forward Rate of Return (Yacktman) (%) is ranked lower than
90% of the 92 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 12.13 vs. OCPNY: -11.24 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) (%) only.
OCPNY' s 10-Year Forward Rate of Return (Yacktman) (%) Range
Min: -34.6  Med: -11.20 Max: 7.5
Current: -11.24
-34.6
7.5

Business Description

Industry: Medical Instruments & Equipment » Medical Instruments & Supplies
Compare:TSE:4543, TSE:4151, WST, TSE:7732, TSE:7541 » details
Traded in other countries:7733.Japan, OLY1.Germany,
Olympus Corp was incorporated in Japan on October 12, 1919. The Company is engaged in manufacturing and selling of precision machineries and instruments. The Company operates in four segments including Medical Business, Life Science and Industrial Business, Imaging Business, and Others. The Medical Business segment is engaged in manufacturing & selling of medical endoscopes, surgical endoscopes, endotherapy devices and other products including endoscopy systems includes videoscopes, video processors, light sources, and liquid crystal display (LCD) panels; peripheral equipment including image recording device, endoscope cleaning systems, and sterilization systems; surgical devices including surgical video endoscopy systems, peripheral devices for endoscopic surgery, and electrosurgical knives. The Life Science and Industrial Business segment is engaged in the manufacturing & selling of biological microscopes, industrial microscopes, industrial endoscopes, non-destructive testing equipment and other products. The Imaging Business segment is engaged in manufacturing and selling of digital cameras, voice recorders and other products. The Others business segment manufactures and sells biomedical materials and conducts system development and other business activities.
» More Articles for OCPNY

Headlines

Articles On GuruFocus.com
David Herro Comments on Olympus Oct 07 2014 
David Herro's Oakmark International Fund Third Quarter 2014 Letter Oct 07 2014 
T. Rowe Price Japan Fund’s Top 5 New Buys Jul 17 2013 
David Herro Comments on Olympus Corp. Apr 23 2013 
David Herro's Oakmark International Fund Q1 2013 Commentary Apr 23 2013 
Olympus' Efforts to Improve Corporate Governance Leave Room for More Sep 28 2012 

More From Other Websites
Is Japan’s Corporate Culture Ready for a Close-up? Aug 20 2015
Antibiotic-resistant 'superbug' found at California hospital Aug 19 2015
Antibiotic-resistant 'superbug' found at California hospital Aug 19 2015
Olympus Corp. Earnings Q2*, 2015 Aug 19 2015
Toshiba foresees loss after accounting scandal Aug 18 2015
Toshiba foresees loss after accounting scandal Aug 18 2015
FDA: scope manufacturer waited years to report problems Aug 17 2015
FDA: scope manufacturer waited years to report problems Aug 17 2015
CEO of Japan's Toshiba resigns over doctored books Jul 21 2015
CEO of Japan's Toshiba resigns over doctored books Jul 21 2015
CEO of Japan's Toshiba to resign over doctored books Jul 21 2015
CEO of Japan's Toshiba to resign over doctored books Jul 21 2015
Sony plays to strengths in games, sensors as it vows revival Apr 30 2015
Sony plays to strengths in games, sensors as it vows revival Apr 30 2015
Lawmaker questions maker of scopes tied to 'superbug' issues Mar 24 2015
Lawmaker questions maker of scopes tied to 'superbug' issues Mar 24 2015

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK